Posts
November 14 2017
Aspen REIT, Inc. filed with the Securities and Exchange Commission for a Regulation A+ offering, the proceeds of which will be used to purchase the St. Regis Aspen Resort. EG&S is acting as counsel to Maxim Group LLC, the lead selling agent for the offering.
November 14 2017
Helios and Matheson Analytics Inc. (“HMNY”), a provider of information technology services and solutions, and MoviePass Inc., a movie-theater subscription service, which provides film enthusiasts with a variety of subscription options to enhance their movie-going experience, announced that HMNY has entered into a securities purchase agreement with institutional investors for HMNY to issue convertible notes in the aggregate principal amount of $100,000,000, for the purpose of further funding MoviePass, and for general corporate purposes. EG&S serves as counsel to MoviePass Inc.
November 08 2017
Ellex Medical Lasers Limited announced the closing of their PIPE offering in the amount of $23,000,000. EG&S acted as counsel to Maxim Group LLC, the lead placement agent in the offering.
November 06 2017
Bio-Path Holdings, Inc. announced the closing of their PIPE in the amount of $9,000,000. EG&S acted as counsel to the Placement Agent.
November 03 2017
M III Acquisition Corp. announced that it has entered into a definitive agreement and plan of merger with IEA Energy Services LLC, a leading engineering, procurement and construction company in the renewable energy sector. MIII will be renamed as “Infrastructure and Energy Alternatives, Inc.” upon consummation of the merger and is expected to continue to be listed on the Nasdaq Capital Market under the symbol “IEA”. EG&S acted as special SPAC counsel to MIII.
November 03 2017
Nemus Biosciences, Inc. announced the closing of their PIPE offering in the amount of $2,000,000. EG&S acted as counsel to the sole investor.
November 02 2017
Global Partner Acquisition Corp. (“GPAC”) and Purple Innovation, LLC (“Purple”) announced that they have entered into a definitive merger agreement pursuant to which Purple will become a subsidiary of GPAC, based on an initial enterprise value of Purple of approximately $900 million. The consummation of the merger will be subject to the terms and conditions set forth in the agreement. EG&S acted as counsel to GPAC.
October 31 2017
NeuroMetrix Inc. announced the closing of their PIPE offering in the amount of $3,500,000. EG&S acted as counsel to the Lead Investor.